Normative:Antibody

Normative

Encyclopaedic information

Neutralizing antibodies directed at the receptor-binding domain of SARS-CoV-2 spike protein have been evaluated as prophylactic and therapeutic agents for COVID-19.

Source: https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-covid-19-gl-tx-and-mgmt-v4.4.1.pdf

Examples

Transplant recipients who are hospitalized with mild to moderate COVID-19 may be considered for anti-SARS-CoV-2 monoclonal antibodies that are available through expanded access programs.

Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf

Collocations

• monoclonal antibodies
• anti-SARS-CoV-2 antibodies
• neutralizing antibodies
• antibody response
• antibody titers

Keyness

• antibody: 150
• monoclonal antibody: 45
• anti-sars-cov-2 monoclonal antibody: 50
• neutralizing antibody: 96
• antibody titer: 582